Solgar Polska Accused Of Price Fixing Dietary Supplements in Poland
Executive Summary
Evidence uncovered at the headquarters of Solgar Polska indicates the firm has since 2010 been instructing retailers to fix prices for its wide range of supplements, according to the national competition regulator. The company is now facing a full investigation and potentially a substantial fine.
You may also be interested in...
Solgar Polska Slapped With Fine For Price Fixing Dietary Supplements
Solgar Polska has been hit with a fine in excess of PLN1.5m for colluding with retailers to set minimum prices for its dietary supplements over almost a decade. The company denies any wrongdoing and has vowed to appeal the judgment.
OTCs Under Threat In Europe: Calls To Reverse-Switch Codeine And Others In Poland And Ireland
Poland's ministry of health is calling for codeine, dextromethorphan and pseudoephedrine to be reverse-switched from OTC to prescription status in response to abuse of the drugs by adolescents. At the same time, an academic paper argues Ireland should restrict codeine to prescription-only sale to combat an addiction epidemic "verging on eruption."
Polish Consumers Finding It Harder To Access OTC Drugs
Trend of pharmacy closures in 2018 threatens Polish consumers' access to consumer health products, insists local OTC association PASMI. Over 90% of OTC sales in Poland currently go through pharmacies.